Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology
- PMID: 20934395
- PMCID: PMC5527923
- DOI: 10.1016/j.molonc.2010.09.001
Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology
Abstract
Emerging proteomic tools and mass spectrometry play pivotal roles in protein identification, quantification and characterization, even in complex biological samples. The cancer secretome, namely the whole collection of proteins secreted by cancer cells through various secretory pathways, has only recently been shown to have significant potential for diverse applications in oncoproteomics. For example, secreted proteins might represent putative tumor biomarkers or therapeutic targets for various types of cancer. Consequently, many proteomic strategies for secretome analysis have been extensively deployed over the last few years. These efforts generated a large amount of information awaiting deeper mining, better understanding and careful interpretation. Distinct sub-fields, such as degradomics, exosome proteomics and tumor-host cell interactions have been developed, in an attempt to provide certain answers to partially elucidated mechanisms of cancer pathobiology. In this review, advances, concerns and challenges in the field of secretome analysis as well as possible clinical applications are discussed.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5527923/bin/MOL2-4-496-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5527923/bin/MOL2-4-496-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5527923/bin/MOL2-4-496-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5527923/bin/MOL2-4-496-g004.gif)
Similar articles
-
Exploring the macromolecules for secretory pathway in cancer disease.Adv Protein Chem Struct Biol. 2023;133:55-83. doi: 10.1016/bs.apcsb.2022.10.003. Epub 2022 Nov 9. Adv Protein Chem Struct Biol. 2023. PMID: 36707206
-
Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.Expert Rev Proteomics. 2017 Nov;14(11):1021-1035. doi: 10.1080/14789450.2017.1387053. Epub 2017 Oct 6. Expert Rev Proteomics. 2017. PMID: 28967788 Review.
-
Proteomic approaches to decipher cancer cell secretome.Semin Cell Dev Biol. 2018 Jun;78:93-101. doi: 10.1016/j.semcdb.2017.06.030. Epub 2017 Jul 3. Semin Cell Dev Biol. 2018. PMID: 28684183 Review.
-
The secretome signature of malignant mesothelioma cell lines.J Proteomics. 2016 Aug 11;145:3-10. doi: 10.1016/j.jprot.2016.02.021. Epub 2016 Feb 26. J Proteomics. 2016. PMID: 26921831
-
Oncoproteomics: Trials and tribulations.Proteomics Clin Appl. 2016 Apr;10(4):516-31. doi: 10.1002/prca.201500081. Epub 2015 Dec 9. Proteomics Clin Appl. 2016. PMID: 26518147 Review.
Cited by
-
Unveiling the mechanistic link between extracellular amyloid fibrils, mechano-signaling and YAP activation in cancer.Cell Death Dis. 2024 Jan 11;15(1):28. doi: 10.1038/s41419-024-06424-z. Cell Death Dis. 2024. PMID: 38199984 Free PMC article.
-
Inhibition of ERO1a and IDO1 improves dendritic cell infiltration into pancreatic ductal adenocarcinoma.Front Immunol. 2023 Dec 22;14:1264012. doi: 10.3389/fimmu.2023.1264012. eCollection 2023. Front Immunol. 2023. PMID: 38187398 Free PMC article.
-
A Subset of Colon Cancer Cell Lines Displays a Cytokine Profile Linked to Angiogenesis, EMT and Invasion Which Is Modulated by the Culture Conditions In Vitro.Cells. 2023 Oct 29;12(21):2539. doi: 10.3390/cells12212539. Cells. 2023. PMID: 37947617 Free PMC article.
-
Calcium-binding Cab45 regulates the polarized apical secretion of soluble proteins in epithelial cells.Mol Biol Cell. 2023 Jul 1;34(8):br12. doi: 10.1091/mbc.E22-12-0549. Epub 2023 May 10. Mol Biol Cell. 2023. PMID: 37163315 Free PMC article.
-
Cancer Cell-Derived PDGFB Stimulates mTORC1 Activation in Renal Carcinoma.Int J Mol Sci. 2023 Mar 29;24(7):6447. doi: 10.3390/ijms24076447. Int J Mol Sci. 2023. PMID: 37047421 Free PMC article.
References
-
- Aebersold, R. , Mann, M. , 2003. Mass spectrometry-based proteomics. Nature. 422, (6928) 198–207. - PubMed
-
- Bendtsen, J.D. , Jensen, L.J. , 2004. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des Sel. 17, (4) 349–356. - PubMed
-
- Bendtsen, J.D. , Nielsen, H. , 2004. Improved prediction of signal peptides: signalP 3.0. J. Mol. Biol. 340, (4) 783–795. - PubMed
-
- Bialkowska, K. , Zaffran, Y. , 2003. 14-3-3 zeta mediates integrin-induced activation of Cdc42 and Rac. Platelet glycoprotein Ib-IX regulates integrin-induced signaling by sequestering 14-3-3 zeta. J. Biol. Chem. 278, (35) 33342–33350. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources